- Home
- ABTS vs EVOK Comparison
ABTS vs EVOK Comparison
Compare ABTS & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABTS
- EVOK
- Stock Information
- Founded
- ABTS 2010
- EVOK 2007
- Country
- ABTS Hong Kong
- EVOK United States
- Employees
- ABTS N/A
- EVOK N/A
- Industry
- ABTS Computer Software: Programming Data Processing
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- ABTS Technology
- EVOK Health Care
- Exchange
- ABTS Nasdaq
- EVOK Nasdaq
- Market Cap
- ABTS 4.6M
- EVOK 4.2M
- IPO Year
- ABTS N/A
- EVOK 2013
- Fundamental
- Price
- ABTS $4.77
- EVOK $2.95
- Analyst Decision
- ABTS
- EVOK
- Analyst Count
- ABTS 0
- EVOK 0
- Target Price
- ABTS N/A
- EVOK N/A
- AVG Volume (30 Days)
- ABTS 397.7K
- EVOK 14.3K
- Earning Date
- ABTS 04-30-2025
- EVOK 05-13-2025
- Dividend Yield
- ABTS N/A
- EVOK N/A
- EPS Growth
- ABTS N/A
- EVOK N/A
- EPS
- ABTS N/A
- EVOK N/A
- Revenue
- ABTS $6,711,225.00
- EVOK $11,594,083.00
- Revenue This Year
- ABTS N/A
- EVOK $57.82
- Revenue Next Year
- ABTS N/A
- EVOK $59.12
- P/E Ratio
- ABTS N/A
- EVOK N/A
- Revenue Growth
- ABTS 299.11
- EVOK 89.89
- 52 Week Low
- ABTS $1.35
- EVOK $1.94
- 52 Week High
- ABTS $14.10
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- ABTS 59.34
- EVOK 38.86
- Support Level
- ABTS $3.75
- EVOK $3.33
- Resistance Level
- ABTS $4.40
- EVOK $3.66
- Average True Range (ATR)
- ABTS 0.53
- EVOK 0.29
- MACD
- ABTS 0.01
- EVOK -0.06
- Stochastic Oscillator
- ABTS 100.00
- EVOK 2.99
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.